84
Participants
Start Date
July 31, 2009
Primary Completion Date
October 29, 2012
Study Completion Date
October 29, 2012
CS-7017
CS-7017
Placebo
Placebo
H.Clinic I Provincial de Barcelona, Barcelona
Institute for Cancer Research and Treatment - IRCC, Candiolo
Clinica Universitaria de Navarra, Pamplona
Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine
Service d'Oncologie Medicale, Rennes
Centre Hospitalier Prive Saint Gregoire, Saint-Grégoire
Sumy Regional Oncology Center, Sumy
Policlinico Santa Maria alle Scotte, Siena
Fakulti nemocnice Brno, Brno
Nemocnice Znojmo, p.o., Oddeleni radiacni a klinicke onkologie, Znojmo
Hopitaux civils de colmar, Colmar
Hopital Edouard Herriot, Lyon
Fakultni nemocnice Olomouc, Olomouc
Klinikum rechts der Isar, München
Onkologische Praxis Donauwörth, Donauwörth
Russian Oncology Research Centre n.a. Blokhin, RAMS, Moscow
Central Clinical Hospital #1, Moscow
NUZ Semashko Central Clinical Hospital, Moscow
Federal State Institution of Healthcare Clinical Hospital # 122 n.a.L.G Sokolov, Saint Petersburg
St-Petersburg State Institution of Public Health, Saint Petersburg
Medical Radiological Research Centre, Obninsk
Tula Regional Oncology dispensary, Tula
Kazan State Medical University, Kazan'
Universitätsklinikum Halle Klinik und Poliklinik für Innere Medizin, Halle
Ospedale San Martino, Genova
Unita Operativa di Oncologia Medica, Lecce
Volyn regional oncology dispensary, Lutsk
Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie w Bialymstoku, Bialystok
Wojewodzki Szpital Specjalistyczny, Bytom
Centrum Onkologii Instytut im. Marii Sklodowskiej-Curie, Gliwice
VESALIUS Sp. z o.o., Krakow
NZOZ ONKOLOG s.c., Warsaw
Hospital Mútua de Terrassa, Terrassa (Barcelona)
Kyiv City Oncology Hospital, Kiev
Mount Vernon Cancer Centre, Northwood
Aberdeen Royal Infirmary, Aberdeen
St.Bartholomew's Hospital, London
UCLH Cancer Clinical Trials Unit, London
Christie Hospital, Manchester
Lead Sponsor
Daiichi Sankyo
INDUSTRY